The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation.

about

The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation.

Item

http://www.wikidata.org/entity/Q47179802

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation.

@en

The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation.

@nl

type

Item

label

The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation.

@en

The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation.

@nl

prefLabel

The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation.

@en

The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation.

@nl

P1476

The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation.

@en

P2093

Anthony J Hatswell

http://www.w3.org/2001/XMLSchema#string

Ayesha Akbar

http://www.w3.org/2001/XMLSchema#string

Emily-Ruth Marriott

http://www.w3.org/2001/XMLSchema#string

Peter Lichtlen

http://www.w3.org/2001/XMLSchema#string

P2860

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

Functional bowel disorders

Impact of functional gastrointestinal disorders on survival in the community.

Efficacy and safety of lubiprostone in patients with chronic constipation.

Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction.

The burden of constipation on quality of life: results of a multinational survey.

Constipation and risk of cardiovascular disease among postmenopausal women.

Long-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipation

The LUCK study: Laxative Usage in patients with GP-diagnosed Constipation in the UK, within the general population and in pregnancy. An epidemiological study using the General Practice Research Database (GPRD).

Cost-effectiveness of prucalopride in the treatment of chronic constipation in the Netherlands

P2888

s41669-017-0065-9

P304

241-253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S41669-017-0065-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Becky Pennington

P577

2018-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29302926

http://www.w3.org/2001/XMLSchema#string

P932

6103927

http://www.w3.org/2001/XMLSchema#string